3 ms·
>>In single payer system, those therapies aren't even discussed with the patient since the physician knows if it's not paid for by the gov't it's effectively ou
by gambiting 5y ago
>>In single payer system, those therapies aren't even discussed with the patient since the physician knows if it's not paid for by the gov't it's effectively out of reach.
I genuienly don't think that's as common as you think it is.
Anecdote time: when my dad was diagnosed with GIST in Poland(you know, not a very wealthy country), his prognosis was about 6-12 months if lucky. But the doctors at the oncology unit knew that the drug Glivec was being approved against GIST but not yet refunded by the Polish healthcare system. They basically applied and got approved to fund his therapy along with 5 other people(GIST was and remains super rare). The national healthcare system paid for his treatment with Glivec for the next 8 years(until he died), despite the huge cost of the medication.
Like, maybe he was lucky. But again, I think you are misrepresenting the system by saying "doctors won't even try". Sure, maybe some won't. Some will. I've heard similar stories from US where doctors won't order certain medically necessary treatment because they know insurers won't pay for it - it doesn't mean anything in isolation.
- refurb 5y agoI have no idea what the timing was but Gleevec was first approved in the US 20 years ago. It was an old drug by the early 2010’s. And that’s what I’ve observed. Yes, in universal systems you’ll get cancer care, but you’ll get the standard of care from 5-10 years ago. All the while cancer can has advanced by leaps and bounds.
- gambiting 5y agoWell, maybe. In my dad's case he started treatment in 2003, so I don't think it was that long after the first approval in the US.